HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

'Landmine' Of Consequences In Nutrition, Supplement Facts Label Changes

This article was originally published in The Rose Sheet

Executive Summary

FDA’s final rule updating Nutrition Facts labels will have a far-reaching impact on products beyond labeling. The requirements also will change nutrient daily values, potentially affecting product claims and the way in which consumers perceive products, say food consultants during an FDLI webinar.

You may also be interested in...



Small Firms Get Year Reprieve From Compliance With US FDA’s Supplement Facts Label Changes

FDA has heard from some manufacturers that additional time is needed to meet all of the requirements, “especially during the COVID-19 pandemic.” Prior to the pandemic, agency announced enforcement discretion during 2020 for compliance by firms with more than $10m in annual sales.

Compliance For ‘Gluten Free’ Claims For Fermented, Hydrolyzed Supplements Relies On Recordkeeping

Final rule amends FDA regulation on gluten-free labeling to provide alternative means for the agency to verify compliance. It will determine whether a firm is compliant from records it must maintain, and make available for inspection and copying, of the fermented or hydrolyzed supplements and food products bearing the claim.

HBW Market Roundup: Prop 65 Amendment Off, Enforcement Discretion Asked For Label Compliance, More

California withdraws Prop 65 proposal to clarify when and how average concentrations can be calculated for a listed chemical due to deadline; trade groups ask FDA for enforcement discretion on compliance date for Nutrition and Supplement Facts labels rules; FDA published list of necessary records for FSVP applications; and use of OTC analgesics grows in teen suicide attempts.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108460

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel